Why tyrosinase for treatment of melanoma.
Song
Y H
YH
Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville 32610-0275, USA.
D000818:Animals; D000943:Antigens, Differentiation / Q000032:analysis; D001324:Autoantigens / Q000032:analysis; D001327:Autoimmune Diseases / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D004195:Disease Models, Animal; D006801:Humans; D008213:Lymphocyte Activation / Q000276:immunology; D008544:Melanocytes / Q000276:immunology; D008545:Melanoma / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D014442:Monophenol Monooxygenase / Q000276:immunology / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D014820:Vitiligo / Q000150:complications / Q000276:immunology
D000943:Antigens, Differentiation; D001324:Autoantigens; D014442:Monophenol Monooxygenase